JPS55373A - Medicinal compound - Google Patents

Medicinal compound

Info

Publication number
JPS55373A
JPS55373A JP5532279A JP5532279A JPS55373A JP S55373 A JPS55373 A JP S55373A JP 5532279 A JP5532279 A JP 5532279A JP 5532279 A JP5532279 A JP 5532279A JP S55373 A JPS55373 A JP S55373A
Authority
JP
Japan
Prior art keywords
formula
compound
compound shown
medicines
reacted
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP5532279A
Other languages
English (en)
Other versions
JPS626555B2 (ja
Inventor
Takayuki Naito
Susumu Nakagawa
Tetsuo Yamazaki
Takaaki Okita
Akihiro Yamashita
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
BRISTOL MAYERS KENKYUSHO KK
Bristol Banyu Research Institute Ltd
Original Assignee
BRISTOL MAYERS KENKYUSHO KK
Bristol Banyu Research Institute Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by BRISTOL MAYERS KENKYUSHO KK, Bristol Banyu Research Institute Ltd filed Critical BRISTOL MAYERS KENKYUSHO KK
Publication of JPS55373A publication Critical patent/JPS55373A/ja
Publication of JPS626555B2 publication Critical patent/JPS626555B2/ja
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D473/00Heterocyclic compounds containing purine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
JP5532279A 1978-05-09 1979-05-08 Medicinal compound Granted JPS55373A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/904,146 US4172829A (en) 1978-05-09 1978-05-09 2,9-Disubstituted adenine derivatives and their use as non-adrenergic bronchodilators

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP61214083A Division JPS62116583A (ja) 1978-05-09 1986-09-12 プリン誘導体

Publications (2)

Publication Number Publication Date
JPS55373A true JPS55373A (en) 1980-01-05
JPS626555B2 JPS626555B2 (ja) 1987-02-12

Family

ID=25418652

Family Applications (2)

Application Number Title Priority Date Filing Date
JP5532279A Granted JPS55373A (en) 1978-05-09 1979-05-08 Medicinal compound
JP61214083A Granted JPS62116583A (ja) 1978-05-09 1986-09-12 プリン誘導体

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP61214083A Granted JPS62116583A (ja) 1978-05-09 1986-09-12 プリン誘導体

Country Status (19)

Country Link
US (1) US4172829A (ja)
JP (2) JPS55373A (ja)
AU (1) AU532056B2 (ja)
BE (1) BE876122A (ja)
CA (1) CA1109871A (ja)
CH (1) CH640534A5 (ja)
DE (1) DE2918261A1 (ja)
DK (1) DK145698C (ja)
FI (1) FI66615C (ja)
FR (2) FR2432519A1 (ja)
GB (2) GB2097785B (ja)
GR (1) GR73535B (ja)
IE (1) IE48216B1 (ja)
IT (1) IT1116833B (ja)
LU (1) LU81238A1 (ja)
NL (1) NL7903650A (ja)
SE (2) SE436033B (ja)
YU (1) YU41632B (ja)
ZA (1) ZA792186B (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4370213A (en) * 1980-05-29 1983-01-25 Ngk Insulators, Ltd. Oxygen sensor

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI802401A (fi) * 1979-08-06 1981-02-07 Bristol Myers Co Bronkutvidgande purin
US4232155A (en) * 1979-09-13 1980-11-04 Bristol-Myers Company Purine compounds
US4269839A (en) * 1979-09-13 1981-05-26 Bristol-Myers Company Alkylthio-adenines used as bronchodilators
US4278675A (en) * 1979-09-13 1981-07-14 Bristol-Myers Company Bronchodilating process
US4286093A (en) * 1980-02-25 1981-08-25 Mead Johnson & Company 9-Cyclohexyl-2-alkoxy-9H-adenine process
US4419358A (en) * 1981-11-12 1983-12-06 Mead Johnson & Company Isethionic acid salt of 9-cyclohexyl-2-propoxy-9H-purine-6-amine and compositions containing an effective bronchodilating concentration of it
US5015739A (en) * 1988-04-22 1991-05-14 Schering Corporation Processes for preparation of cyclopentyl purine derivatives
JPH027537A (ja) * 1988-06-27 1990-01-11 Dainippon Printing Co Ltd 移動装置及び形状測定装置
US4999428A (en) * 1989-04-14 1991-03-12 Schering Corporation Process for preparing cyclopentyl purine derivatives
JPH0379236U (ja) * 1990-08-24 1991-08-13
JPH0379235U (ja) * 1990-08-24 1991-08-13
WO2000068230A1 (en) * 1999-05-05 2000-11-16 Darwin Discovery Limited 9-(1,2,3,4-tetrahydronaphthalen-1-yl)-1,9-dihydropurin-6-one derivatives as pde7 inhibitors
DE60011787T2 (de) * 1999-09-10 2005-07-14 Stichting Rega V.Z.W. Carbocyclische nukleoside und verfahren zu deren herstellung
CN1501928A (zh) * 2000-11-02 2004-06-02 斯隆-凯特林癌症研究所 结合hsp90的小分子组合物
US9879014B2 (en) 2013-07-12 2018-01-30 Kyoto University Method for screening substance capable of inhibiting abnormal splicing causative of onset or progress of disease

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3930005A (en) * 1973-06-15 1975-12-30 Squibb & Sons Inc Antiinflammatory agents and their use
US3917837A (en) * 1974-10-21 1975-11-04 American Cyanamid Co Method of using trans-2-(6-amino-9H-purin-9-yl)-cyclopentanol
JPS5271492A (en) * 1975-12-10 1977-06-14 Kohjin Co Ltd Synthesis of 9-substituted-2-substituted thioadenines
DE2610985A1 (de) 1976-03-16 1977-09-29 Byk Gulden Lomberg Chem Fab Arzneimittel enthaltend beta-d-1 (6-amino-9h-purin-9-yl)-1-deoxyribofuranuronsaeurederivate
US4076711A (en) * 1976-04-05 1978-02-28 Schering Corporation Triazolo [4,5-d]-pyrimidines

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4370213A (en) * 1980-05-29 1983-01-25 Ngk Insulators, Ltd. Oxygen sensor

Also Published As

Publication number Publication date
CH640534A5 (de) 1984-01-13
SE449864B (sv) 1987-05-25
AU532056B2 (en) 1983-09-15
JPH0146515B2 (ja) 1989-10-09
ZA792186B (en) 1980-05-28
GB2020655A (en) 1979-11-21
IE790878L (en) 1979-11-09
FR2429793B1 (ja) 1983-02-04
JPS62116583A (ja) 1987-05-28
AU4689679A (en) 1979-11-15
IT7948986A0 (it) 1979-05-09
DE2918261A1 (de) 1979-11-15
BE876122A (fr) 1979-11-08
YU108579A (en) 1983-12-31
DK188279A (da) 1979-11-10
SE7903976L (sv) 1979-11-10
FR2432519B1 (ja) 1983-02-04
SE8401493L (sv) 1984-03-16
LU81238A1 (fr) 1979-12-07
YU41632B (en) 1987-12-31
DE2918261C2 (ja) 1988-08-04
IE48216B1 (en) 1984-10-31
FR2429793A1 (fr) 1980-01-25
FR2432519A1 (fr) 1980-02-29
IT1116833B (it) 1986-02-10
FI791456A (fi) 1979-11-10
JPS626555B2 (ja) 1987-02-12
FI66615C (fi) 1984-11-12
SE8401493D0 (sv) 1984-03-16
DK145698C (da) 1983-07-25
FI66615B (fi) 1984-07-31
DK145698B (da) 1983-01-31
GB2097785A (en) 1982-11-10
NL7903650A (nl) 1979-11-13
US4172829A (en) 1979-10-30
GB2020655B (en) 1982-08-25
CA1109871A (en) 1981-09-29
GR73535B (ja) 1984-03-12
GB2097785B (en) 1983-03-23
SE436033B (sv) 1984-11-05

Similar Documents

Publication Publication Date Title
JPS55373A (en) Medicinal compound
HK89790A (en) Novel carbostyril derivative and process for preparing same
ES8307806A1 (es) "procedimiento para la preparacion de 1,2-a piridinas y pirazinas".
HUT45021A (en) Process for production of insecticides and acaricides containing pirasoline-derivatives as active substance and process for production of the active substances
HUT42080A (en) Process for producing labdane derivatives and pharmaceutical compositions containing them
IE811513L (en) Benzisoselenazolones
ES8200094A1 (es) Procedimiento para la obtencion de alquilureas
EP0176118A3 (en) Oligosaccharides containing galactopyranose units for therapeutic or diagnostic use, a process and intermediates for their preparation
ES2001703A6 (es) Procedimiento para la preparracion de derrrivados de acidos 2-(2-imidazolin -2-il)- piridin -3- carboxilicos.
GEP19981040B (en) Process for preparation of (2-morpholinophenyl) guanidine or pharmaceutical suitable salts thereof
HU903092D0 (en) Process for the preparation of buten-carboxylic acid derivatives and pharmaceutical compositions containing such compounds
PT76693A (en) (-)-15-deoxyspergualin a process for the preparation of the same an intermediate of the same and its use as medicament
IE780397L (en) Guanines.
HUT46214A (en) Process for producing medical preparation suitable for treatment of peptic ulcer
EP0294069A3 (en) Purine compounds, process for their preparation, intermediates and pharmaceutical compositions
ES8107191A1 (es) Procedimiento para la preparacion de 2-(2-cloro-4-ciclopro- pil-fenil-imino)-imidazolidina
DE3061787D1 (en) Process for preparing derivatives of 6-amino-6-desoxy-2,3-0-isopropylidene-alpha-l-sorbofuranose and intermediates of the process
EP0073345A3 (en) Sydnonimine derivatives, process for production thereof, and use thereof
GB967594A (en) 2-(2,6-dimethyl-3-hydroxy-4-tert-butyl-benzyl)-2-imidazoline,and acid addition salts thereof,and process for their manufacture
JPS54103891A (en) Novel 2-fluoro-adenosine-3',5'-cyclic phosphoric acid and its preparation
JPS565499A (en) Preparation of thymine derivative
EP0024866A3 (en) Mildiomycin analogs, process for their preparation and pesticidal agents thereof
DE3570662D1 (en) Arphamenine derivatives, a process for their preparation and their use as medicament
JPS57106668A (en) Preparation of n,n'-bis-(3-(3',4',5'-trimethoxybenzoyloxy)- propyl)homopiperazine
DE3379224D1 (en) 3-methoxy-n-methylmorphinane : theophyllinacetic acid (1:2) complex, process for preparing the same and said complex for therapeutical use